While Russell 2000 lags major indexes, Dave, GeneDx, Root lead small-cap stocks with massive gains. Which small cap stocks to ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of ...

Advances in genetic testing, enable the identification of genetic causes even before symptoms appear, allowing for timely ...

The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...

DNA Sequencing Market Fueled by Genomics Research, Personalized Medicine, and AI-Powered Advancements, the DNA Sequencing <a target=_blank ...

全外显子基因检测是一种针对家族性疾病、遗传代谢性疾病以及罕见疾病的检测技术。它是对蛋白编码的序列直接测序，从而发现蛋白结构的变异，还能发现变异频率低于1%的罕见变异。该检测主要用于寻找遗传疾病相关的基因变异情况，进行遗传病的诊断、鉴别诊断、排除诊断， ...

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients ...

全外显子基因检测是一种针对家族性疾病、遗传代谢性疾病以及罕见疾病的检测技术。它是对蛋白编码的序列直接测序，从而发现蛋白结构的变异，还能发现变异频率低于1%的罕见变异。该检测主要用于寻找遗传疾病相关的基因变异情况，进行遗传病的诊断、鉴别诊断、排除诊断， ...